Investigation of safety and efficacy of cardiac rehabilitation for pulmonary hypertension
Conditions
Interventions
Cardiac rehabilitation
Sponsors
The University of Tokyo Hospital
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. Males and females who is 20 years old or over. 2. Patients who are treated for pulmonary arterial hypertension or chronic thromboembolic pulmonary hypertension in the Univeresity of Tokyo Hospital and whose mean pulmonary arterial pressures are under 25 mmHg within 6 month before starting this clinical trial. 3. Patients with informed consent for clinical trial enrollment.
Exclusion criteria
Exclusion criteria: 1. Patients who are not appropriate for excercise 2. Patients in whom excercise is thought to be contraindication or who are at high risk for complication of excercise (Patients with severe valvular diseases, severe arrythmia, severe renal dysfunction, severe hepatic dysfunction, and carcinoma) 3. Patients with dimentia 4. Patientsin the terminal phase of the disease 5. Patients with pregnancy
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Comparison of morality, the ratio of the patients with adverse cardiovascular events, the ratio of the patients who needed intensive treatment, and the ratio of the patients with addmision during non-intervention period (3months) and rehabilitation period (3month). | — |
Countries
Japan
Contacts
Public ContactTakayuki Fujiwara
The University of Tokyo Hospital Department of Computational Diagnostic Radiology and Preventive Medicine
Outcome results
None listed